Single FT1050 treated UCB unit
FT1050-02
Phase 1 mab completed
Quick answer
Single FT1050 treated UCB unit for Non-Hodgkin's Lymphoma (NHL) is a Phase 1 program (mab) at FATE THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- FATE THERAPEUTICS INC
- Indication
- Non-Hodgkin's Lymphoma (NHL)
- Phase
- Phase 1
- Modality
- mab
- Status
- completed